C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/2004
10/21/2004	WO2004043989A3 Human monoclonal antibodies to heparanase
10/21/2004	WO2004043405A3 Polysaccharide vaccine for staphylococcal infections
10/21/2004	WO2004032832A3 Bispecific molecule comprising an anti-cr1 antibody cross-linked to an antigen-binding antibody fragment
10/21/2004	WO2004009776A3 TREATMENT OF TNFα RELATED DISORDERS
10/21/2004	WO2003062375A3 Stabilizing polypeptides which have been exposed to urea
10/21/2004	WO2003027266A3 Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof
10/21/2004	WO2003026490A3 Methods and compositions for prevention, diagnosis, and treatment of cancer using bispecific molecules
10/21/2004	WO2003025120A3 Clasp membrane proteins
10/21/2004	WO2003024392A3 Compositions and methods for the diagnosis and treatment of tumor
10/21/2004	WO2003000014A3 Spherical protein particles and methods of making and using them
10/21/2004	WO1995027066A9 Dna encoding ubiquitin conjugating enzymes
10/21/2004	US20040210950 Methods and compositions relating to muscle specific sarcomeric calcineurin-binding proteins (CALSARCINS)
10/21/2004	US20040210040 Monoclonal antibodies for use in the prevention and treatment of cell proliferative and skin disorders; immunotherapy; antitumor agents
10/21/2004	US20040210038 Il-1 eta DNA and polypeptides
10/21/2004	US20040210037 Comprises major histocompatibility complex fusion protein for use in treating and/or preventing cancer, infection, allergies and autoimmune diseases
10/21/2004	US20040209834 mouse double minute (MDM); determining the mdm2-dependent growth activity of a cell by introducing vectors for expressing a p53 polypeptide or fragment into the cell, and measuring the growth of the cell
10/21/2004	US20040209805 such as fibrosis via activin antagonist (fullistatin); kits; gene therapy; treating inflammatory bowel disease and crohn's disease
10/21/2004	US20040209379 Diagnosis and monitoring of diseases
10/21/2004	US20040209356 incubating isomaltulose with sorbitol dehydrogenase; host cells
10/21/2004	US20040209330 Preparing immunoglobulins for use in diagnosis, prevention and treatment of psoriasis, inflammation and infection
10/21/2004	US20040209324 Comprises genetically altered thrombopoietin for use in treatment of thrombocytopenia; gene therapy and therapeutic proteins
10/21/2004	US20040209318 Reagents and methods for the detection and quantification of vancomycin in bilogical fluids
10/21/2004	US20040209310 Ligands that bind to the amyloid-beta precursor peptide and related molecules and uses thereof
10/21/2004	US20040209309 Compositions and methods for the specific detection of mammalian muscle proteins
10/21/2004	US20040209306 Novel proteins in enteroaggregative escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections
10/21/2004	US20040209296 Using transcription factor inhibitors and human leukocyte antigen antibodies to prevent and treatcell proliferfative disorders; genetic vaccines and antitumor agents
10/21/2004	US20040209289 BTL-II nucleic acids, proteins, and antibodies
10/21/2004	US20040209286 Comprises nucleotide sequences coding g protein coupled receptors for use in identifying modulators of sweet taste transduction; food processing; improving palatability of low-calorie beverages through the development of new artificial sweeteners
10/21/2004	US20040209264 Comprises nucleotide sequences coding daugther of legless protein for use in identifying modulator for tissue regeneration and repair and the treatment of blood disorders
10/21/2004	US20040209248 Comprises modified viral surface protein for use in detection and diagnosis of hepatitis infection
10/21/2004	US20040209244 Anti-dengue virus antibodies, compositions, methods and uses
10/21/2004	US20040208899 Apparatus for diagnosis and treatment of swine infertility and respiratory virus (SIRS) syndrome; vaccines
10/21/2004	US20040208887 human monoclonal antibodies against hepatiti c E1 antigen, reagent with such antibodies, vaccine; treating or preventing HCV infection by administration of the vaccine composition
10/21/2004	US20040208879 Flt4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy
10/21/2004	US20040208878 Treatment of acute lung injury, fibrosis and metastasis with antagonists of alphabetav6
10/21/2004	US20040208877 Antibodies and uses thereof
10/21/2004	US20040208876 Monoclonal antibodies to hepatocyte growth factor
10/21/2004	US20040208874 Treating a tumor necrosis factor (TNF)- alpha mediated disease by administering TNF- alpha inhibitor and a B7gene or protein inhibitor and/or a CD28/antigen/ inhibitor; antiinflammatory agents; arthritis, autoimmune diseases, inflammatory bowel disease, psoriasis, lupus, graft versus host disease
10/21/2004	US20040208873 Produced in hybridoma, transfectoma or in non-human transgenic animal; capable of producing multiple isotypes of human monoclonal antibodies by undergoing recombination and isotype switching; antiinflammatory agents
10/21/2004	US20040208871 Pharmaceutical composition containing inhibitors of interferon-gamma
10/21/2004	US20040208868 Antibody that binds to phosphatidyl serine comprising a CDR of the monoclonal antibody 3G4 produced by hybridoma; anticarcinogenic, antitumor, and viricidal agents; angiogenesis inhibitors
10/21/2004	US20040208866 Methods of regulating body weight
10/21/2004	US20040208865 Immune complexes
10/21/2004	CA2563393A1 Ml - iap peptides induce anti-melanoma cytotoxic t-cell response
10/21/2004	CA2521997A1 Antiobestic agent using hen's egg antibody against digestive enzymes
10/21/2004	CA2521402A1 Pectate lyases, nucleic acids encoding them and methods for making and using them
10/21/2004	CA2521375A1 Cancerous disease modifying antibodies
10/21/2004	CA2521303A1 The use of pde4d in the screening for medicaments against atherosclerosis
10/21/2004	CA2521273A1 Peptides, polypeptides, and proteins of reduced immunogenicity and methods for their production
10/21/2004	CA2520987A1 Targets for tumor growth inhibition
10/21/2004	CA2520866A1 Phosphodiesterase 2a and methods of use
10/21/2004	CA2520803A1 Phosphodiesterase 10a7 isoforms and methods of use
10/21/2004	CA2520121A1 Inhibitors of integrin alpha5beta1 and their use for the control of tissue granulation
10/21/2004	CA2501222A1 Antibody recognizing antigen
10/20/2004	EP1469316A1 Screening method
10/20/2004	EP1469310A1 Diagnostic for scleroderma
10/20/2004	EP1469072A2 Means and methods for diagnosing and treating affective disorders
10/20/2004	EP1469065A1 Composition of antibody specifically binding to cd20
10/20/2004	EP1468695A1 Methods and compositions useful for inhibition of angiogenesis
10/20/2004	EP1468614A1 Method of improving the growth or the efficiency of feed conversion of an animal and composition for use therein
10/20/2004	EP1468293A1 Diagnostic and therapeutic use of the voltage-gated ion channel scn2a for neurodegenerative diseases
10/20/2004	EP1468097A2 METHODS OF GENERATING MULTISPECIFIC, MULTIVALENT AGENTS FROM V sb H /sb AND V sb L /sb DOMAINS
10/20/2004	EP1468022A1 Novel monoclonal antibody and nematode larval antigens
10/20/2004	EP1468019A2 Secreted protein
10/20/2004	EP1468018A2 Leptin proteins
10/20/2004	EP1468012A1 Biomolecule transduction motif mph-1-btm and the use thereof
10/20/2004	EP1467801A1 Method of prophylaxis against large myocardial infarctions
10/20/2004	EP1467759A2 Compositions and methods related to tim-3, a th1-specific cell surface molecule
10/20/2004	EP1467758A2 Methods for preparing immunoconjugates
10/20/2004	EP1467757A2 Use of antibodies against the muc18 antigen
10/20/2004	EP1467756A2 Methods for using anti-muc18 antibodies
10/20/2004	EP1467752A1 HUMAN MAST CELL−EXPRESSED MEMBRANE PROTEINS
10/20/2004	EP1467615A1 Methods to engineer mammalian-type carbohydrate structures
10/20/2004	EP1194450B1 Inactivated vaccine against feline calicivirus disease
10/20/2004	EP1179179B1 Use of an antibody to detect basophiles and/or mast cells
10/20/2004	EP1104772B1 Anti-l7/l12 antibody for detecting bacteria
10/20/2004	EP0959895B1 Peptides responsive to antibodies against a consensus peptide of the cs4-cfa/i family proteins
10/20/2004	EP0939796A4 Uses of oncofetal antigen specific cd4, cd8 cytotoxic and suppressor t cells and interleukin-10
10/20/2004	EP0935604A4 Magnetically activated cell sorting for production of proteins
10/20/2004	EP0904107B1 Immunoglobin-like domains with increased half lives
10/20/2004	EP0886644B1 Long wavelength engineered fluorescent proteins
10/20/2004	EP0778891B1 Monoclonal recombinant anti-rhesus d (d7c2) antibody
10/20/2004	EP0734451B1 ENTEROTOXINS OF SHIGELLA FLEXNERI 2a
10/20/2004	EP0732939B1 Preparation and use of immunoconjugates comprising a VL-chain glycosylated at the Asn in position 18
10/20/2004	EP0658113B1 Isolated nonapeptide derived from mage-3 gene and presented by hla-a1, and uses thereof
10/20/2004	CN1538853A T cell regulatory genes and methods of use thereof
10/20/2004	CN1537952A New alginate monoclone antiboeg and its preparation method and use
10/20/2004	CN1171997C Modified TLE-2-receptor ligands
10/20/2004	CN1171903C Wheat high-molecular-weight glutelin subunit monoclonal anitbody and its hybrid tumor cell line
10/20/2004	CN1171902C Antisercretory factor petides regulating pathological permeability changes
10/20/2004	CN1171901C New interferon-like protein and its code sequence and use
10/20/2004	CN1171900C Novel, ubiquitous potassium-channel proteins and genes for the same
10/20/2004	CN1171638C Sugar chain-recognizing antibody and remedy for infection with HIV
10/19/2004	US6806360 Nucleic acids encoding human tissue factor inhibitor
10/19/2004	US6806354 Methods and compositions for inducing autoimmunity in the treatment of cancers
10/19/2004	US6806352 Nucleotide sequences coding membrane proteins/pro-polypeptides; anticarcinogenic/antitumor agents
10/19/2004	US6806351 Nucleotide sequences coding proteins for use in the diagnosis and treatment of hematopoietic or immune disorders
10/19/2004	US6806255 Compounds and methods for modulating adhesion molecule function
10/19/2004	US6806254 An isolated polynucleotide containing a nucleotide sequence with a specific sequence, translated protein coding protion, mature protein coding protion, extracellular portion or the active domain, codes a polypeptide
10/19/2004	US6806253 Therapeutic and preventive anti-bacterial vaccine complex

1 ... 793 794 795 796 797 798 799 800 801 802 803 804 805 806 807 808 809 810 811 812 813 ... 1494